Join the watch

Gilead Sciences, Inc.

$73.26
GILD - NASDAQ
Dividend yield
-
Payout ratio
-
P/E (12m)
-
EPS
-
Gilead Sciences, Inc. description

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands.

The company was founded by Michael L.

Company profile
Market cap
Mega (92.57B)
Company CEO
Daniel O'Day
GILD dividends payouts